dihexa human clinical trials data AngIV-Analog Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway Dihexa Timeline: What the Evidence

DSIP (delta sleep-inducing peptide) is a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from rabbit cerebral venous blood

It was first identified in human plasma and later became widely studied for its potential influence on tissue regeneration, collagen synthesis, and cellular repair mechanisms

Long term prescription of medications such as the following are likely to increase the cause of, or exacerbate the risk of B12 deficiency - the proton pump inhibitors (esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole), famotidine, ranitidine, metformin, glibenclamide, gliclazide, glimepiride, glipizide, sodium valproate, gabapentin, doxycycline, some oral contraceptives

These findings indicate that Dihexa rescued the cognitive ability of APP/PS1 mice

Cold chain: All peptides ship as lyophilized (freeze-dried) powder and are stable at room temperature during transit

Detection windows vary by frequency of use, body composition, and test sensitivity, but can extend from days to several weeks after the last use